Insider Trading & Ownership of James N. Topper

Location
Palo Alto, CA
Summary
The estimated net worth of James N. Topper is at least $183M dollars as of 17 Sep 2025. James N. Topper is the Director of NewAmsterdam Pharma Co N.V. and owns shares of NewAmsterdam Pharma Co N.V. (NAMS) stock worth about $163M. James N. Topper is the Director, 10%+ Owner of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $19.6M. James N. Topper is the Director, 10%+ Owner of ANAPTYSBIO, INC and owns shares of ANAPTYSBIO, INC (ANAB) stock worth about $85.1K.
Signature
/s/ Steve R. Bailey, Attorney-in-Fact For James N. Topper
All Insider Reports
All Insider Reports

Notify me when James N. Topper files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of James N. Topper

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NAMS, NAMSW NewAmsterdam Pharma Co N.V. Director $163M +$405K +0.25% 15 Sep 2025
PHAT Phathom Pharmaceuticals, Inc. Director, 10%+ Owner $19.6M +$192K +0.99% 03 Jun 2025
ANAB ANAPTYSBIO, INC Director, 10%+ Owner $85.1K 06 Jan 2023
ALPN ALPINE IMMUNE SCIENCES, INC. Director $0 18 May 2024

Insider Transactions Reported by James N. Topper:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.